Page last updated: 2024-09-05

l 778,123 and Dysmyelopoietic Syndromes

l 778,123 has been researched along with Dysmyelopoietic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, XK; Li, B; Meyer, P; Preisler, HD; Raza, A	1

Other Studies

1 other study(ies) available for l 778,123 and Dysmyelopoietic Syndromes

Article	Year
The effects of the farnesyl transferase inhibitor FTI L-778,123 on normal, myelodysplastic, and myeloid leukemia bone marrow progenitor proliferation in vitro. Leukemia & lymphoma, 2003, Volume: 44, Issue:1 Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Bone Marrow Cells; Case-Control Studies; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Imidazoles; Leukemia, Myeloid; Myelodysplastic Syndromes; Neoplastic Stem Cells	2003

Article

Year

The effects of the farnesyl transferase inhibitor FTI L-778,123 on normal, myelodysplastic, and myeloid leukemia bone marrow progenitor proliferation in vitro.

Leukemia & lymphoma, 2003, Volume: 44, Issue:1

Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Bone Marrow Cells; Case-Control Studies; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Imidazoles; Leukemia, Myeloid; Myelodysplastic Syndromes; Neoplastic Stem Cells

2003